glutathione approved by fda highlights concerns with using dietary ingredient to compound sterile injectables ISHIN is FDA Approved -

Those who experienced severe GI side effects on tirzepatide or semaglutide that required treatment discontinuation should proceed with extreme caution, as the combination will likely produce similar or potentially more pronounced effects

I dont agree with people who harp on about its not regulated

Hoogland, Netherlands Institute for Neuroscience, Netherlands Reviewed by Mark E

All points

Watanabe group demonstrated that the inhibition of SLC7A11 including SAS treatment may overcome resistance to vorinostat by accumulating ROS and inducing ferroptosis in human breast cancer cell and colon cancer cell (Miyamoto et al., 2020)

A Guide to Safe Support is worth reading